Cargando…
Management of persistent acromegaly following primary therapy: The current landscape in the UK
Acromegaly is the clinical consequence of chronic exposure of the tissues to excess GH and IGF‐I. It is almost exclusively the result of a GH‐secreting pituitary adenoma. In addition to the somatic features, uncontrolled acromegaly is associated with a number of complications and excess mortality. M...
Autores principales: | Kyriakakis, Nikolaos, Seejore, Khyatisha, Hanafy, Ahmed, Murray, Robert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375072/ https://www.ncbi.nlm.nih.gov/pubmed/32704572 http://dx.doi.org/10.1002/edm2.158 |
Ejemplares similares
-
SUN-085 Assessing the Impact of Disease Activity on Clot Formation and Lysis in Patients with Acromegaly
por: Kyriakakis, Nikolaos, et al.
Publicado: (2019) -
SUN-075 Higher Fibrinogen and Clot Density in Patients with Acromegaly: The Role of Adverse Body Composition to the Increased Thrombotic Potential
por: Kyriakakis, Nikolaos, et al.
Publicado: (2019) -
MON-302 The Prevalence of Acromegaly in the Sleep Apnoea Clinic
por: Lynch, Julie Marie, et al.
Publicado: (2020) -
MON-621 A Second Course of Antithyroid Drug Therapy Is Effective in Patients with Relapsed Graves' Disease
por: Seejore, Khyatisha, et al.
Publicado: (2019) -
Evaluation of cardiovascular risk factors in long-term survivors of adult- and childhood-onset brain tumours: a pilot study
por: Kyriakakis, Nikolaos, et al.
Publicado: (2021)